slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,566
Current window 87,871-87,900
Pages 3,986
Rows per page 30
Component
87,871-87,900 of 119,566
36
Includes a footnote regarding EBITDA calculation and a reference to the Eutelsat-OneWeb combination.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Satisfaction1 hit
38
Includes a satellite imagery visual on the right.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Satisfaction1 hit
45
The slide highlights the strategic positioning of Eutelsat following the OneWeb merger and E10B satellite deployment.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Satisfaction1 hit
47
The slide explicitly notes this is the standalone outlook, excluding the impact of the OneWeb combination.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Satisfaction1 hit
48
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations Beat · Satisfaction1 hit
58
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
61
The map illustrates the complementary nature of GEO (targeted high-demand areas) and LEO (global coverage) satellite networks.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
70
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
01
Includes company logo and date.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
13
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
16
The slide uses a process flow diagram to illustrate a clinical case study.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
18
The slide uses a horizontal process-like layout to showcase four distinct pillars of their R&D engine.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
22
The slide illustrates a drug discovery workflow using MPO (Multiparameter Optimisation) to balance multiple biological and chemical constraints.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
24
The slide features a 3D molecular model and a UI overlay displaying various pharmacological parameters (potency, selectivity, stability, etc.) and a merit score.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
27
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
29
The visual depicts a molecular structure, likely representing the drug candidate or its target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
31
The slide uses a human anatomy diagram to map patient counts to specific disease locations.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Visualization1 hit
37
The slide features a 3D molecular visualization of the inhibitor.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
39
The slide uses a human anatomy diagram to map specific cancer types to their respective incidence numbers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
40
Includes a biological pathway diagram and a honeycomb-style indication map.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
47
The slide features a 3D molecular visualization of the protein target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
48
TPP stands for Target Product Profile.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
50
The slide uses a process-flow layout to describe the company's R&D methodology.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
51
The visual background is a stylized molecular structure, emphasizing the biotech/pharma context.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
61
The slide uses a two-column layout to contrast PK data with Toxicology/Safety data.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
63
The slide uses a stylized molecular visualization as a background, typical of biotech pitch decks.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
69
The slide uses a process-based framework to show how MD and AI are integrated into a drug discovery workflow.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
70
The image shows a protein binding site with color-coded regions (Donor, Apolar, Acceptor) indicating chemical properties.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
73
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
74
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit